Related references
Note: Only part of the references are listed.3,5-diiodothyronine (3,5-T2) reduces blood glucose independently of insulin sensitization in obese mice
S. da Silva Teixeira et al.
ACTA PHYSIOLOGICA (2017)
The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation
Marta Szydlowska et al.
GENE EXPRESSION (2017)
Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells
Michael Rogowski et al.
FEBS OPEN BIO (2017)
Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet
Rosalba Senese et al.
FRONTIERS IN PHYSIOLOGY (2017)
Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet
Liliana F. Iannucci et al.
SCIENTIFIC REPORTS (2017)
Thyroid hormones derivatives reduce proliferation and induce cell death and DNA damage in ovarian cancer
Elena Shinderman-Maman et al.
SCIENTIFIC REPORTS (2017)
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted networkmeta-analysis
Rosa Lombardi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer
Elisabetta Puliga et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition
Brijesh K. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair
Andrea Perra et al.
ENDOCRINE-RELATED CANCER (2016)
Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration
Tamara Feliciano Alvarado et al.
GENE EXPRESSION (2016)
Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant -catenin
Junyan Tao et al.
HEPATOLOGY (2016)
Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease
Teruki Miyake et al.
INTERNAL MEDICINE (2016)
Essential role of UCP1 modulating the central effects of thyroid hormones on energy balance
Mayte Alvarez-Crespo et al.
MOLECULAR METABOLISM (2016)
3,5-Diiodo-L-Thyronine (3,5-T2) Exerts Thyromimetic Effects on Hypothalamus-Pituitary-Thyroid Axis, Body Composition, and Energy Metabolism in Male Diet-Induced Obese Mice
Wenke Jonas et al.
ENDOCRINOLOGY (2015)
New insights into the structure and mechanism of iodothyronine deiodinases
Ulrich Schweizer et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
Local Hypothyroidism Favors the Progression of Preneoplastic Lesions to Hepatocellular Carcinoma in Rats
Carla Frau et al.
HEPATOLOGY (2015)
Emerging Trends in Hepatocellular Carcinoma Incidence and Mortality
Basile Njei et al.
HEPATOLOGY (2015)
The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice
Alexandro J. Martagon et al.
PLOS ONE (2015)
3,5-Diiodothyronine (T2) is on a role. A new hormone in search of recognition
Aurea Orozco et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2014)
Thyroid: biological actions of 'nonclassical' thyroid hormones
Rosalba Senese et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Uptake and metabolic effects of 3-iodothyronamine in hepatocytes
Sandra Ghelardoni et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia
Martha J. Kelly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern
Veronica Mariotti et al.
PLOS ONE (2014)
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
Barbara Sjouke et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
Daniel F. Vatner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
Rebecca Taub et al.
ATHEROSCLEROSIS (2013)
Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling
Rafael Arrojo e Drigo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone
Shalini Thakran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T1AM treatment
J. A. Haviland et al.
OBESITY (2013)
SIRT1 is a Direct Coactivator of Thyroid Hormone Receptor β1 with Gene-Specific Actions
Ji Ho Suh et al.
PLOS ONE (2013)
Thyroid Hormone Analogues: Where Do We Stand in 2013?
Sunitha Meruvu et al.
THYROID (2013)
Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related Diseases
Hsiang Cheng Chi et al.
BIOMED RESEARCH INTERNATIONAL (2013)
3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice
Maria Elena Manni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling
Rudolf Zechner et al.
CELL METABOLISM (2012)
Detection of 3-Iodothyronamine in Human Patients: A Preliminary Study
Elena Galli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy
Rohit Anthony Sinha et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver
Elena Grasselli et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Nonthyrotoxic Prevention of Diet-Induced Insulin Resistance by 3,5-Diiodo-L-Thyronine in Rats
Pieter de Lange et al.
DIABETES (2011)
Thyronamines-Past, Present, and Future
S. Piehl et al.
ENDOCRINE REVIEWS (2011)
Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell Line
Anna Vila-Brau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Evidence for Extrathyroidal Formation of 3-Iodothyronamine in Humans as Provided by a Novel Monoclonal Antibody-Based Chemiluminescent Serum Immunoassay
Carolin S. Hoefig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Direct effects of iodothyronines on excess fat storage in rat hepatocytes
Elena Grasselli et al.
JOURNAL OF HEPATOLOGY (2011)
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P. Zambad et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2011)
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine
Alessandro Saba et al.
ENDOCRINOLOGY (2010)
TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet
Federica Cioffi et al.
FASEB JOURNAL (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
TRβ is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells
Marta A. Kowalik et al.
JOURNAL OF HEPATOLOGY (2010)
3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?
Alexandra G. Ianculescu et al.
MOLECULAR BIOSYSTEMS (2010)
Pathways affected by 3,5-diiodo-L-thyronine in liver of high fat-fed rats: Evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry
Elena Silvestri et al.
MOLECULAR BIOSYSTEMS (2010)
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Paul W. Ladenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Thyroid Hormone Receptor Ligands Induce Regression of Rat Preneoplastic Liver Lesions Causing Their Reversion to a Differentiated Phenotype
Andrea Perra et al.
HEPATOLOGY (2009)
Reduction of Hepatic Steatosis in Rats and Mice After Treatment with a Liver-Targeted Thyroid Hormone Receptor Agonist
Edward E. Cable et al.
HEPATOLOGY (2009)
Association Between Hypothyroidism and Hepatocellular Carcinoma: A Case-Control Study in the United States
Manal M. Hassan et al.
HEPATOLOGY (2009)
Central effects of thyronamines on glucose metabolism in rats
Lars P. Klieverik et al.
JOURNAL OF ENDOCRINOLOGY (2009)
A TRβ-selective agonist confers resistance to diet-induced obesity
Beatriz S. Amorim et al.
JOURNAL OF ENDOCRINOLOGY (2009)
3,5-diiodo-L-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet
Maria Pina Mollica et al.
JOURNAL OF HEPATOLOGY (2009)
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
John D. Baxter et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration
A. Columbano et al.
CELL PROLIFERATION (2008)
Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats
Andrea Perra et al.
FASEB JOURNAL (2008)
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
Catherine Postic et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Animal models of NASH: Getting both pathology and metabolic context right
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
Mark D. Erion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model
Reeta Vetelaeinen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Sirtuins in mammals: insights into their biological function
Shaday Michan et al.
BIOCHEMICAL JOURNAL (2007)
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function
Grazia Chiellini et al.
FASEB JOURNAL (2007)
Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy
M. Bockhorn et al.
EUROPEAN SURGICAL RESEARCH (2007)
Hypothyroidism: A possible risk factor for liver cancer in patients with no known underlying cause of liver disease
Arvind Reddy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Trace amine-associated receptors and their ligands
R. Zucchi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The thyroid hormone receptor-β agonist GC-1 induces cell proliferation in rat liver and pancreas
Amedeo Columbano et al.
ENDOCRINOLOGY (2006)
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
JK Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Mechanisms of Disease: hepatic steatosis in type 2 diabetes - pathogenesis and clinical relevance
Michael Roden
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2006)
Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential - A study relevant to donor preconditioning
R Malik et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
3-iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
TS Scanlan et al.
NATURE MEDICINE (2004)
Selective activators of thyroid hormone receptors
P Webb
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor
S Borngraeber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective thyroid hormone receptor-β activation:: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability
GJ Grover et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Thyroid receptor ligands.: 1.: Agonist ligands selective for the thyroid receptor β1
L Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Overexpression of the sarcoplasmic reticulum Ca2+-ATPase improves myocardial contractility in diabetic cardiomyopathy
SU Trost et al.
DIABETES (2002)
Physiological and molecular basis of thyroid hormone action
PM Yen
PHYSIOLOGICAL REVIEWS (2001)
Nuclear hormone receptors and gene expression
A Aranda et al.
PHYSIOLOGICAL REVIEWS (2001)
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3)
M Pibiri et al.
FASEB JOURNAL (2001)
Mechanisms of disease: Thyroid hormone and the cardiovascular system.
I Klein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
